Dongbang Medical Co., Ltd (KOSDAQ:240550)

Market Cap	220.38B
Revenue (ttm)	108.48B
Net Income (ttm)	3.72B
Shares Out	20.81M
EPS (ttm)	214.90
PE Ratio	49.28
Forward PE	10.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	222,252
Average Volume	181,444
Open	10,700
Previous Close	10,840
Day's Range	10,510 - 10,760
52-Week Range	9,100 - 15,490
Beta	n/a
RSI	40.21
Earnings Date	Aug 26, 2025

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1985
• Employees: 269
• Stock Exchange: KOSDAQ
• Ticker Symbol: 240550

Financial Performance

In 2024, Dongbang Medical's revenue was 105.11 billion, an increase of 15.67% compared to the previous year's 90.88 billion. Earnings were 2.91 billion, a decrease of -70.19%.